Drug Trial Radar · NCT00694369
A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)
Last checked: Nov 19, 2026Latest source record: Feb 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
588
Actual
Start
Jun 2008
Primary completion
Dec 2008
Study completion Jan 2009
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- Jun 10, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the pain relieving effect of different doses of MK0663 with placebo and other pain relievers/analgesics in patients with postoperative dental pain. Pain intensity and relief will be measured by the total pain relief score (TOPAR) and patient evaluation.
Conditions
- Postoperative Dental Pain
Interventions
Comparator: etoricoxibDrug
etoricoxib 90 mg; 120 mg (once daily) over three days.
Comparator: ibuprofenDrug
ibuprofen 2400 mg (600 mg Q6h) over three Days
Comparator: acetaminophen + codeineDrug
acetaminophen 2400 mg/codeine 240 mg (600/60 mg Q6h) over three Days
Comparator: placeboDrug
matching placebo over three Days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Pain Relief Score Over the First 6 Hours Post the Initial Day 1 Dose of the Study Medication (TOPAR6)Time frame: Over the first 6 hours post the initial Day 1 dose of the study medication
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.